Hossain Md Belal, Uchiyama Yoshikazu, Rajib Samiul Alam, Rahman Akhinur, Takatori Mitsuyoshi, Tan Benjy Jek Yang, Sugata Kenji, Nagashima Mami, Kawakami Mamiyo, Ito Hitoshi, Kumagai Ryota, Sadamasu Kenji, Ogi Yasuhiro, Kawaguchi Tatsuya, Tamura Tomokazu, Fukuhara Takasuke, Ono Masahiro, Yoshimura Kazuhisa, Satou Yorifumi
Division of Genomics and Transcriptomics, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan.
Department of Food Microbiology, Faculty of Nutrition and Food Science, Patuakhali Science and Technology University, Patuakhali, Bangladesh.
Commun Med (Lond). 2024 Aug 9;4(1):161. doi: 10.1038/s43856-024-00582-z.
Highly transmissible viruses including SARS-CoV-2 frequently accumulate novel mutations that are detected via high-throughput sequencing. However, there is a need to develop an alternative rapid and non-expensive approach. Here we developed a novel multiplex DNA detection method Intelli-OVI for analysing existing and novel mutations of SARS-CoV-2.
We have developed Intelli-OVI that includes the micro-disc-based method IntelliPlex and computational algorithms of objective variant identification (OVI). More than 250 SARS-CoV-2 positive samples including wastewater ones were analysed to verify the efficiency of the method.
IntelliPlex uses micro-discs printed with a unique pictorial pattern as a labelling conjugate for DNA probes, and OVI allows simultaneous identification of several variants using multidimensional data obtained by the IntelliPlex method. Importantly, de novo mutations can be identified by decreased signals, which indicates that there is an emergence of de novo variant virus as well as prompts the need to design additional primers and probes. We have upgraded probe panel according to the emergence of new variants and demonstrated that Intelli-OVI efficiently identified more than 20 different SARS-CoV-2 variants by using 35 different probes simultaneously.
Intelli-OVI can be upgraded to keep up with rapidly evolving viruses as we showed in this study using SARS-CoV-2 as an example and may be suitable for other viruses but would need to be validated.
包括严重急性呼吸综合征冠状病毒2(SARS-CoV-2)在内的高传播性病毒经常积累通过高通量测序检测到的新突变。然而,需要开发一种替代的快速且低成本的方法。在此,我们开发了一种用于分析SARS-CoV-2现有和新突变的新型多重DNA检测方法Intelli-OVI。
我们开发了Intelli-OVI,它包括基于微盘的方法IntelliPlex和目标变异识别(OVI)的计算算法。分析了250多个SARS-CoV-2阳性样本,包括废水样本,以验证该方法的效率。
IntelliPlex使用印有独特图案的微盘作为DNA探针的标记共轭物,而OVI允许使用通过IntelliPlex方法获得的多维数据同时识别多个变异。重要的是,新发突变可通过信号降低来识别,这表明出现了新发变异病毒,并提示需要设计额外的引物和探针。我们根据新变异的出现升级了探针组,并证明Intelli-OVI通过同时使用35种不同的探针有效地识别了20多种不同的SARS-CoV-2变异。
正如我们在本研究中以SARS-CoV-2为例所示,Intelli-OVI可以升级以跟上快速进化的病毒,并且可能适用于其他病毒,但需要进行验证。